Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s family, or patient’s healthcare provider that could identify a need, problem, or condition.
Description (*Please confirm or update this field for the new USCDI version*)
Evaluation of a patient's reported use of drugs or other substances for non-medical purposes or in excess of a valid prescription.
Examples include but are not limited to substance use disorder score, and substance use knowledge assessment.
Applicable Vocabulary Standard(s)
Applicable Standards (*Please confirm or update this field for the new USCDI version*)
Logical Observation Identifiers Names and Codes (LOINC®) version 2.74
Submitted By: Jessica Cotto
/ National Institute on Drug Abuse
Data Element Information
Use Case Description(s)
Use Case Description
According to the 2019 National Survey on Drug Use and Health (NSDUH), 20.2% of people ages 12 or older reported past month cigarette use. In addition, 8.1% reported past month cigar use, 4.2% used smokless tobacco and 13% used illicit drugs. In total, nearly 36 million people ages 12 or older reported past month use of illicit drugs in 2019 and 58 million reported use of tobacco in the past month.
Estimate the breadth of applicability of the use case(s) for this data element
This data element has been used at scale between multiple different production environments to support the majority of anticipated stakeholders
Supporting Artifacts
This data element has been used at scale and reviewed for maximum stakeholder impact. Our internal analysis of web traffic to the TAPS website (https://www.drugabuse.gov/taps/ ) in Q3 this year exceeded 6,000 unique page views.
McNeely, J., Wu, L.T., Subramaniam, G., Sharma, G., Cathers, L.A., et al. (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine, 2016 Nov 15;165(10):690-699.
Angéline Adam, Robert P Schwartz, Li-Tzy Wu, Geetha Subramaniam, Eugene Laska, Gaurav Sharma, Saima Mili, Jennifer McNeely. Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool. Addict Sci Clin Pract. 2019 Oct 15;14(1):39.
5 or more. This data element has been tested at scale between multiple different production environments to support the majority of anticipated stakeholders.
Supporting Artifacts
There are 10 registered users for the TAPS Tool API, and we have received about 5 additional inquiries expressing interest in EHR/EMR system integration. None of the registered users are currently active.
Potential Challenges
Restrictions on Standardization (e.g. proprietary code)
The tool is designed to be brief and should take fewer than 5 minutes to administer, but may be completed quicker if the patient does not endorse recent substance use. Clinicians may wish to identify local providers and or specialty care SUD programs to which to refer patients with higher risk levels well before beginning systematic screening. This will greatly assist with finding a suitable referral when the need arises
NCPDP supports the use of LOINC codes for assessments and observations for substance use. NCPDP utilizes LOINC codes in the HL7/NCPDP Pharmacist eCare Plan.
NCPDP recommends the use of RxNorm and SNOMED CT codes in addition to LOINC codes as the NCPDP SCRIPT Standard utilizes these codes.
Submitted by pwilson@ncpdp.org on
NCPDP Comment
NCPDP recommends the use of SNOMED CT codes as the NCPDP SCRIPT Standard utilizes these codes.